nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Pregnancy—Captopril—systemic scleroderma	0.0304	0.0304	CcSEcCtD
Terlipressin—Pregnancy—Mycophenolic acid—systemic scleroderma	0.0239	0.0239	CcSEcCtD
Terlipressin—Fluid overload—Mycophenolic acid—systemic scleroderma	0.0218	0.0218	CcSEcCtD
Terlipressin—Pallor—Captopril—systemic scleroderma	0.0208	0.0208	CcSEcCtD
Terlipressin—Fluid overload—Lisinopril—systemic scleroderma	0.0196	0.0196	CcSEcCtD
Terlipressin—Skin necrosis—Methotrexate—systemic scleroderma	0.0173	0.0173	CcSEcCtD
Terlipressin—Fluid overload—Mycophenolate mofetil—systemic scleroderma	0.0172	0.0172	CcSEcCtD
Terlipressin—Pallor—Leflunomide—systemic scleroderma	0.0171	0.0171	CcSEcCtD
Terlipressin—Pallor—Mycophenolic acid—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Terlipressin—Ventricular fibrillation—Lisinopril—systemic scleroderma	0.0159	0.0159	CcSEcCtD
Terlipressin—Cyanosis—Mycophenolate mofetil—systemic scleroderma	0.0151	0.0151	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Mycophenolic acid—systemic scleroderma	0.015	0.015	CcSEcCtD
Terlipressin—Respiratory failure—Mycophenolic acid—systemic scleroderma	0.0138	0.0138	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Lisinopril—systemic scleroderma	0.0135	0.0135	CcSEcCtD
Terlipressin—Pallor—Mycophenolate mofetil—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Terlipressin—Hyponatraemia—Captopril—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Terlipressin—Pulmonary oedema—Mycophenolic acid—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Mycophenolate mofetil—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Terlipressin—Respiratory failure—Mycophenolate mofetil—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Terlipressin—Pulmonary oedema—Lisinopril—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Terlipressin—Atrial fibrillation—Mycophenolic acid—systemic scleroderma	0.0104	0.0104	CcSEcCtD
Terlipressin—Cardiac failure—Mycophenolic acid—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Terlipressin—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.00987	0.00987	CcSEcCtD
Terlipressin—Pulmonary oedema—Mycophenolate mofetil—systemic scleroderma	0.00951	0.00951	CcSEcCtD
Terlipressin—Atrial fibrillation—Lisinopril—systemic scleroderma	0.00934	0.00934	CcSEcCtD
Terlipressin—Hyponatraemia—Lisinopril—systemic scleroderma	0.00889	0.00889	CcSEcCtD
Terlipressin—Hypertension—Pentoxifylline—systemic scleroderma	0.00858	0.00858	CcSEcCtD
Terlipressin—Cyanosis—Methotrexate—systemic scleroderma	0.00855	0.00855	CcSEcCtD
Terlipressin—Chest pain—Pentoxifylline—systemic scleroderma	0.00846	0.00846	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.0084	0.0084	CcSEcCtD
Terlipressin—Atrial fibrillation—Mycophenolate mofetil—systemic scleroderma	0.00819	0.00819	CcSEcCtD
Terlipressin—Cardiac failure—Mycophenolate mofetil—systemic scleroderma	0.00795	0.00795	CcSEcCtD
Terlipressin—Tachycardia—Pentoxifylline—systemic scleroderma	0.00791	0.00791	CcSEcCtD
Terlipressin—Skin disorder—Pentoxifylline—systemic scleroderma	0.00788	0.00788	CcSEcCtD
Terlipressin—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.00779	0.00779	CcSEcCtD
Terlipressin—Chest pain—Mometasone—systemic scleroderma	0.0073	0.0073	CcSEcCtD
Terlipressin—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00723	0.00723	CcSEcCtD
Terlipressin—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00692	0.00692	CcSEcCtD
Terlipressin—Skin exfoliation—Prednisone—systemic scleroderma	0.00692	0.00692	CcSEcCtD
Terlipressin—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Terlipressin—Myocardial infarction—Lisinopril—systemic scleroderma	0.00669	0.00669	CcSEcCtD
Terlipressin—Cardiac disorder—Leflunomide—systemic scleroderma	0.00662	0.00662	CcSEcCtD
Terlipressin—Pulmonary oedema—Prednisone—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Terlipressin—Chest pain—Captopril—systemic scleroderma	0.00641	0.00641	CcSEcCtD
Terlipressin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00641	0.00641	CcSEcCtD
Terlipressin—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00631	0.00631	CcSEcCtD
Terlipressin—Dyspnoea—Mometasone—systemic scleroderma	0.00624	0.00624	CcSEcCtD
Terlipressin—Bradycardia—Lisinopril—systemic scleroderma	0.00624	0.00624	CcSEcCtD
Terlipressin—Malnutrition—Leflunomide—systemic scleroderma	0.00621	0.00621	CcSEcCtD
Terlipressin—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Terlipressin—Respiratory failure—Methotrexate—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Terlipressin—Tachycardia—Captopril—systemic scleroderma	0.006	0.006	CcSEcCtD
Terlipressin—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00592	0.00592	CcSEcCtD
Terlipressin—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00589	0.00589	CcSEcCtD
Terlipressin—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00586	0.00586	CcSEcCtD
Terlipressin—Skin exfoliation—Methotrexate—systemic scleroderma	0.00578	0.00578	CcSEcCtD
Terlipressin—Angiopathy—Lisinopril—systemic scleroderma	0.00556	0.00556	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00556	0.00556	CcSEcCtD
Terlipressin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00555	0.00555	CcSEcCtD
Terlipressin—Abdominal pain—Mometasone—systemic scleroderma	0.00553	0.00553	CcSEcCtD
Terlipressin—Dyspnoea—Captopril—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Terlipressin—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Terlipressin—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Terlipressin—Cardiac failure—Prednisone—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Terlipressin—Hypertension—Leflunomide—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Terlipressin—Malnutrition—Lisinopril—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Terlipressin—Chest pain—Leflunomide—systemic scleroderma	0.00528	0.00528	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Terlipressin—Skin disorder—Azathioprine—systemic scleroderma	0.00521	0.00521	CcSEcCtD
Terlipressin—Vomiting—Pentoxifylline—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Terlipressin—Hypertension—Mycophenolic acid—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Terlipressin—Headache—Pentoxifylline—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Terlipressin—Chest pain—Mycophenolic acid—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Terlipressin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00498	0.00498	CcSEcCtD
Terlipressin—Nervous system disorder—Leflunomide—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Terlipressin—Tachycardia—Leflunomide—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Terlipressin—Skin disorder—Leflunomide—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Terlipressin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Terlipressin—Abdominal pain—Captopril—systemic scleroderma	0.00486	0.00486	CcSEcCtD
Terlipressin—Nausea—Pentoxifylline—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Terlipressin—Diarrhoea—Mometasone—systemic scleroderma	0.00479	0.00479	CcSEcCtD
Terlipressin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Terlipressin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00472	0.00472	CcSEcCtD
Terlipressin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Terlipressin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Terlipressin—Chest pain—Lisinopril—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Terlipressin—Dyspnoea—Leflunomide—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00451	0.00451	CcSEcCtD
Terlipressin—Vomiting—Mometasone—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Terlipressin—Headache—Mometasone—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Terlipressin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Terlipressin—Tachycardia—Lisinopril—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Terlipressin—Abdominal pain—Azathioprine—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Terlipressin—Skin disorder—Lisinopril—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Terlipressin—Diarrhoea—Captopril—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Terlipressin—Nausea—Mometasone—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Terlipressin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Terlipressin—Abdominal pain—Leflunomide—systemic scleroderma	0.004	0.004	CcSEcCtD
Terlipressin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.004	0.004	CcSEcCtD
Terlipressin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Terlipressin—Myocardial infarction—Prednisone—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Terlipressin—Vomiting—Captopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Terlipressin—Dyspnoea—Lisinopril—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Terlipressin—Headache—Captopril—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Terlipressin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Terlipressin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Terlipressin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Terlipressin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Terlipressin—Bradycardia—Prednisone—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Terlipressin—Diarrhoea—Azathioprine—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Terlipressin—Nausea—Captopril—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Terlipressin—Diarrhoea—Leflunomide—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Terlipressin—Abdominal pain—Lisinopril—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Terlipressin—Vomiting—Azathioprine—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Terlipressin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Terlipressin—Headache—Azathioprine—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Terlipressin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Terlipressin—Angiopathy—Prednisone—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Terlipressin—Vomiting—Leflunomide—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Terlipressin—Nausea—Azathioprine—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Terlipressin—Headache—Leflunomide—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Terlipressin—Malnutrition—Prednisone—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Terlipressin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Terlipressin—Headache—Mycophenolic acid—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Terlipressin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Terlipressin—Nausea—Leflunomide—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Terlipressin—Diarrhoea—Lisinopril—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Terlipressin—Nausea—Mycophenolic acid—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Terlipressin—Cardiac disorder—Methotrexate—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Terlipressin—Vomiting—Lisinopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Terlipressin—Angiopathy—Methotrexate—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Terlipressin—Hypertension—Prednisone—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Terlipressin—Headache—Lisinopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Terlipressin—Malnutrition—Methotrexate—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Terlipressin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Terlipressin—Nausea—Lisinopril—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Terlipressin—Nervous system disorder—Prednisone—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Terlipressin—Tachycardia—Prednisone—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Terlipressin—Skin disorder—Prednisone—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Terlipressin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Terlipressin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Terlipressin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Terlipressin—Chest pain—Methotrexate—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Terlipressin—Nervous system disorder—Methotrexate—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Terlipressin—Skin disorder—Methotrexate—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Terlipressin—Abdominal pain—Prednisone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Terlipressin—Dyspnoea—Methotrexate—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Terlipressin—Diarrhoea—Prednisone—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Terlipressin—Abdominal pain—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Terlipressin—Vomiting—Prednisone—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Terlipressin—Headache—Prednisone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Terlipressin—Nausea—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Terlipressin—Diarrhoea—Methotrexate—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Terlipressin—Vomiting—Methotrexate—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Terlipressin—Headache—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Terlipressin—Nausea—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
